Gordon, K.; Papp, K.; Gooderman, M.; Thaci, D.; Foley, P.; Morita, A.; Kundu, S.; Kisa, R.; Napoli, A.; Banerjee, S. Influence of Baseline demographics/Disease Characteristics on Efficacy of an Oral Selective TYK2 Inhibitor, BMS-986165, in Patients With Moderate to Severe Plaque Psoriasis: Phase 2, Randomized, Placebo-Controlled Trial. J of Skin 2019, 3, S14.